Skip to main content
Log in

Cost-Effectiveness and Value of Information Analysis of Nutritional Support for Preventing Pressure Ulcers in High-risk Patients: Implement Now, Research Later

  • Original Research Article
  • Published:
Applied Health Economics and Health Policy Aims and scope Submit manuscript

Abstract

Background

Pressure ulcers are a major cause of mortality, morbidity, and increased healthcare cost. Nutritional support may reduce the incidence of pressure ulcers in hospitalised patients who are at risk of pressure ulcer and malnutrition.

Objectives

To evaluate the cost-effectiveness of nutritional support in preventing pressure ulcers in high-risk hospitalised patients, and to assess the value of further research to inform the decision to implement this intervention using value of information analysis (VOI).

Methods

The analysis was from the perspective of Queensland Health, Australia using a decision model with evidence derived from a systematic review and meta-analysis. Resources were valued using 2014 prices and the time horizon of the analysis was one year. Monte Carlo simulation was used to estimate net monetary benefits (NB) and to calculate VOI measures.

Results

Compared with standard hospital diet, nutritional support was cost saving at AU$425 per patient, and more effective with an average 0.005 quality-adjusted life years (QALY) gained. At a willingness-to-pay of AU$50,000 per QALY, the incremental NB was AU$675 per patient, with a probability of 87 % that nutritional support is cost-effective. The expected value of perfect information was AU$5 million and the expected value of perfect parameter information was highest for the relative risk of developing a pressure ulcer at AU$2.5 million. For a future trial investigating the relative effectiveness of the interventions, the expected net benefit of research would be maximised at AU$100,000 with 1,200 patients in each arm if nutritional support was perfectly implemented. The opportunity cost of withholding the decision to implement the intervention until the results of the future study are available would be AU$14 million.

Conclusions

Nutritional support is cost-effective in preventing pressure ulcers in high-risk hospitalised patients compared with standard diet. Future research to reduce decision uncertainty is worthwhile; however, given the opportunity losses associated with delaying the implementation, “implement and research” is the approach recommended for this intervention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. National Pressure Ulcer Advisory Panel (NPUAP) and European Pressure Ulcer Advisory Panel (EPUAP), prevention and treatment of pressure ulcers: clinical practice guideline. Washington, DC: NPUAP; 2009.

  2. Australian Wound Management Association. Pan pacific clinical practice guidelines for the prevention and management of pressure injuries. Osborne Park: Cambridge Media; 2012.

    Google Scholar 

  3. Cuddigan J, Berlowitz D, Ayello EA. Pressure ulcers in America: prevalence, incidence, and implications for the future: an executive summary of the national pressure ulcer advisory panel monograph. Adv Skin Wound Care. 2001;14:208–15

    Article  Google Scholar 

  4. VanGilder C, Amlung S, Harrison P, Meyer S. Results of the 2008–2009 International Pressure Ulcer Prevalence Survey and a 3-year, acute care, unit-specific analysis. Ostomy Wound Manage. 2009;55:39–45.

    PubMed  Google Scholar 

  5. Graves N, Zheng H. The prevalence and incidence of chronic wounds:a literature review. Wound Pract Res. 2014, 22:4–19.

  6. Padula WV, Mishra MK, Makic MB, Sullivan PW. Improving the quality of pressure ulcer care with prevention: a cost-effectiveness analysis. Med Care. 2011;49:385–92.

    PubMed  Google Scholar 

  7. Dealey C, Posnett J, Walker A. The cost of pressure ulcers in the United Kingdom. J Wound Care. 2012, 21:261–262, 264, 266.

  8. Graves N, Birrell FA, Whitby M. Modeling the economic losses from pressure ulcers among hospitalized patients in Australia. Wound Repair Regen. 2005;13:462–7.

    Article  PubMed  Google Scholar 

  9. National Institute for Health and Clinical Excellence. Pressure ulcer prevention: the prevention and management of pressure ulcers in primary and secondary care (CG179). London: The National Institute for Health and Care Excellence; 2014.

    Google Scholar 

  10. Banks M, Bauer J, Graves N, Ash S. Malnutrition and pressure ulcer risk in adults in Australian health care facilities. Nutrition. 2010;26:896–901.

    Article  PubMed  Google Scholar 

  11. Stratton RGC, Elia M. Disease-related malnutrition: an evidence-based approach to treatment. Wallingford: CABI Publishing; 2003.

    Google Scholar 

  12. Delmi M, Rapin CH, Bengoa JM, Delmas PD, Vasey H, Bonjour JP. Dietary supplementation in elderly patients with fractured neck of the femur. Lancet. 1990;335:1013–6.

    Article  CAS  PubMed  Google Scholar 

  13. Ek AC, Unosson M, Larsson J, Von Schenck H, Bjurulf P. The development and healing of pressure sores related to the nutritional state. Clin Nutr. 1991;10:245–50.

    Article  CAS  PubMed  Google Scholar 

  14. Bourdel-Marchasson I, Barateau M, Rondeau V, Dequae-Merchadou L, Salles-Montaudon N, Emeriau JP, Manciet G, Dartigues JF. A multi-center trial of the effects of oral nutritional supplementation in critically ill older inpatients. GAGE Group. Groupe Aquitain Geriatrique d’Evaluation. Nutrition. 2000;16:1–5.

    Article  CAS  PubMed  Google Scholar 

  15. Houwing RH, Rozendaal M, Wouters-Wesseling W, Beulens JW, Buskens E, Haalboom JR. A randomised, double-blind assessment of the effect of nutritional supplementation on the prevention of pressure ulcers in hip-fracture patients. Clin Nutr. 2003;22:401–5.

    Article  CAS  PubMed  Google Scholar 

  16. Claxton K. Exploring uncertainty in cost-effectiveness analysis. Pharmacoeconomics. 2008;26:781–98.

    Article  PubMed  Google Scholar 

  17. Eckermann S, Willan AR. Time and expected value of sample information wait for no patient. Value Health. 2008;11:522–6.

    Article  PubMed  Google Scholar 

  18. Tuffaha HW, Gordon LG, Scuffham PA. Value of information analysis in healthcare: a review of principles and applications.J. Med Econ. 2014;17:377–83.

    Article  Google Scholar 

  19. Eckermann S, Karnon J, Willan AR. The value of value of information best informing research design and prioritization using current methods. Pharmacoeconomics. 2010;28:699–709.

    Article  PubMed  Google Scholar 

  20. Briggs AH, Goeree R, Blackhouse G, O’Brien BJ: Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Mak 2002, 22:290–308.

  21. Stinnett AA, Mullahy J: Net health benefits: A new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Mak 1998, 18:S68–S80.

  22. Harris AH, Hill SR, Chin G, Li JJ, Walkom E. The role of value for money in public insurance coverage decisions for drugs in Australia: a retrospective analysis 1994–2004. Med Decis Making. 2008;28:713–22.

    Article  PubMed  Google Scholar 

  23. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, Jeejeebhoy KN. What is subjective global assessment of nutritional status? 1987. Classical article. Nutr Hosp. 2008;23:400–7.

    CAS  PubMed  Google Scholar 

  24. Stratton RJ, Ek AC, Engfer M, Moore Z, Rigby P, Wolfe R, Elia M. Enteral nutritional support in prevention and treatment of pressure ulcers: a systematic review and meta-analysis. Ageing Res Rev. 2005;4:422–50.

    Article  PubMed  Google Scholar 

  25. Banks MD, Graves N, Bauer JD, Ash S. Cost effectiveness of nutrition support in the prevention of pressure ulcer in hospitals. Eur J Clin Nutr. 2013;67:42–6.

    Article  CAS  PubMed  Google Scholar 

  26. Olofsson B, Stenvall M, Lundstrom M, Svensson O, Gustafson Y. Malnutrition in hip fracture patients: an intervention study. J Clin Nurs. 2007;16:2027–38.

    Article  PubMed  Google Scholar 

  27. Clemens S, Begum N, Harper C, Whitty JA, Scuffham PA. A comparison of EQ-5D-3L population norms in Queensland, Australia, estimated using utility value sets from Australia, the UK and USA. Qual Life Res. 2014;23(8):2375–81

    Article  PubMed  Google Scholar 

  28. Hawthorne G, Richardson J, Day NA. A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments. Ann Med. 2001;33:358–70.

    Article  CAS  PubMed  Google Scholar 

  29. Essex HN, Clark M, Sims J, Warriner A, Cullum N. Health-related quality of life in hospital inpatients with pressure ulceration: assessment using generic health-related quality of life measures. Wound Repair Regen. 2009;17:797–805.

    Article  PubMed  Google Scholar 

  30. Shemilt I. CCEMG-EPPI-Centre cost converter; Version 1.4. The Campbell and Cochrane Economics Methods Group (CCEMG) and the Evidence for Policy and Practice Information and Coordinating Centre (EPPI-Centre). http://eppi.ioe.ac.uk/costconversion/default.aspx. Acessed July 2014.

  31. Australian hospital statistics 2011–12. Australian Institute of Health and Welfare Canberra. 2013. http://www.aihwgovau/WorkArea/DownloadAssetaspx?id=60129543146. Accessed May 2013.

  32. Claxton K. Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals. Health Econ. 1999;8:269–74.

    Article  CAS  PubMed  Google Scholar 

  33. Ades AE, Lu G, Claxton K. Expected value of sample information calculations in medical decision modeling. Med Decis Mak. 2004, 24:207–227.

  34. Groot Koerkamp B, Myriam Hunink MG, Stijnen T, Weinstein MC. Identifying key parameters in cost-effectiveness analysis using value of information: a comparison of methods. Health Economics. 2006, 15:383–392.

  35. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ. 1999;18:341–64.

    Article  CAS  PubMed  Google Scholar 

  36. Brown CJ, Friedkin RJ, Inouye SK. Prevalence and outcomes of low mobility in hospitalized older patients. J Am Geriatr Soc. 2004;52:1263–70.

    Article  PubMed  Google Scholar 

  37. Claxton KP, Sculpher MJ. Using value of information analysis to prioritise health research: some lessons from recent UK experience. Pharmacoeconomics. 2006;24:1055–68.

    Article  PubMed  Google Scholar 

  38. Claxton K, Posnett J. An economic approach to clinical trial design and research priority-setting. Health Economics. 1996;5:513–24.

    Article  CAS  PubMed  Google Scholar 

  39. Soares MO, Dumville JC, Ashby RL, Iglesias CP, Bojke L, Adderley U, McGinnis E, Stubbs N, Torgerson DJ, Claxton K, Cullum N. Methods to assess cost-effectiveness and value of further research when data are sparse: negative-pressure wound therapy for severe pressure ulcers. Med Decis Making. 2013;33:415–36.

    Article  PubMed  Google Scholar 

  40. Claxton K, Palmer S, Longworth L, Bojke L, Griffin S, McKenna C, Soares M, Spackman E, Youn J. Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development. Health Technol Assess. 2012;16:1–323.

    Article  CAS  PubMed  Google Scholar 

  41. Reddy M, Gill SS, Kalkar SR, Wu W, Anderson PJ, Rochon PA. Treatment of pressure ulcers: a systematic review. JAMA. 2008;300:2647–62.

    Article  CAS  PubMed  Google Scholar 

  42. Pham B, Stern A, Chen W, Sander B, John-Baptiste A, Thein HH, Gomes T, Wodchis WP, Bayoumi A, Machado M, et al. Preventing pressure ulcers in long-term care: a cost-effectiveness analysis. Arch Intern Med. 2011;171:1839–47.

    Article  PubMed  Google Scholar 

  43. McKenna C, Claxton K. Addressing adoption and research design decisions simultaneously: the role of value of sample information analysis. Med Decis Mak. 2011; 31:853–865.

  44. Eckermann S, Willan AR. Expected value of information and decision making in HTA. Health Econ. 2007;16:195–209.

    Article  PubMed  Google Scholar 

  45. Grutters JP, van Asselt MB, Chalkidou K, Joore MA. Healthy decisions: towards uncertainty tolerance in healthcare policy. Pharmacoeconomics. 2014;33(1):1–4. doi:10.1007/s40273-014-0201-7

    Article  Google Scholar 

  46. Dias S, Sutton AJ, Welton NJ, Ades AE. Evidence synthesis for decision making 3: heterogeneity–subgroups, meta-regression, bias, and bias-adjustment. Med Decis Making. 2013;33:618–40.

    Article  PubMed Central  PubMed  Google Scholar 

  47. Willan AR, Eckermann S. Optimal clinical trial design using value of information methods with imperfect implementation. Health Econ. 2010;19:549–61.

    PubMed  Google Scholar 

  48. Allman RM, Goode PS, Burst N, Bartolucci AA, Thomas DR. Pressure ulcers, hospital complications, and disease severity: impact on hospital costs and length of stay. Adv Wound Care. 1999;12:22–30.

    CAS  PubMed  Google Scholar 

  49. Scott IA, Brand CA, Phelps GE, Barker AL, Cameron PA. Using hospital standardised mortality ratios to assess quality of care–proceed with extreme caution. Med J Aust. 2011;194:645–8.

    PubMed  Google Scholar 

  50. Isaia G, Bo M, Tibaldi V, Scarafiotti C, Ruatta C, Michelis G. The experience of a geriatric hospital at home service for acutely ill elderly patients with pressure ulcers. Wounds. 2010;22:121–6.

    Google Scholar 

  51. Brandeis GH, Morris JN, Nash DJ, Lipsitz LA. The epidemiology and natural history of pressure ulcers in elderly nursing home residents. JAMA. 1990;264:2905–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Professor Karl Claxton for his advice regarding EVSI calculations. Haitham Tuffaha is supported by a National Health and Medical Research Council PhD scholarship through the Centre for Research Excellence in Nursing Interventions for Hospitalised Patients. The authors declare no conflict of interest.

Author contributions

Shelly Roberts and Wendy Chaboyer contributed to the development of the model structure and advised the clinical component of the study. Haitham Tuffaha, Louisa Gordon and Paul Scuffham conducted the cost-effectiveness and value of information analyses. All authors contributed to the writing and revision of the manuscript. Haitham Tuffaha is the guarantor for the overall content of the paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Haitham W. Tuffaha.

Appendix

Appendix

EVPI [34]

  1. 1.

    Assigned probability distributions to the input parameters in the mode as summarised in Table 1 in the main text.

  2. 2.

    Sampled random values k times (eg, k = 10,000) from the distributions described above for each intervention.

  3. 3.

    Calculated the mean NB for each intervention across all simulations, and identified the preferred baseline decision, that is, the intervention with the maximum expected mean NB (\( \max_{i} E_{\theta } {\text{NB}}\left( {i,\theta } \right) \)).

  4. 4.

    Calculated the NB for each intervention and identified the optimal intervention at each simulation.

  5. 5.

    Averaged the NBs from the identified optimal interventions in Step 4 (\( E_{\theta } \max_{i} {\text{NB}}\left( {i,\theta } \right) \)).

  6. 6.

    EVPI per-patient is the difference between the average NBs in steps 5 and 3.

EVPPI [34]

Steps 1–3 as in EVPI algorithm detailed above, then:

  1. 4.

    Sampled θ I once from its joint prior distribution (outer-level simulation).

  2. 5.

    Fixed θ I at their sampled values θ Ik and simulate the other remaining uncertain parameters θ Cjk (eg, j = 1,000 times), allowing them to vary according to their conditional probability distribution on θ I at its sampled value θ Ik (inner-level simulation).

  3. 6.

    Calculated the conditional expected NB of each intervention by evaluating the NB at each (θ Cjk, θ Ik) and averaging (\( E_{{\left( {\theta_{C} |\theta_{I} } \right)}} {\text{NB}}\left( {i,\theta_{I} ,\theta_{C} } \right) \)).

  4. 7.

    Identified the intervention that has the highest estimated expected NB given the sampled value for the parameters of interest (θ Ik) from step 6.

  5. 8.

    Repeated steps 4–7 k times (eg, k = 1,000) and calculate the average NB of the preferred interventions identified in step 7 (\( E_{{\theta_{I} }} \max_{i} E_{{\left( {\theta_{C} |\theta_{I} } \right)}} {\text{NB}}\left( {i,\theta_{I} ,\theta_{C} } \right) \)

  6. 9.

    EVPPI is the difference between the average NBs in Steps 8 and 3.

EVSI

To estimate the EVSI for the relative risk (RR) of pressure ulcer with nutritional support (NS) compared to standard care (SC), we assumed that parameters θ NS and θ SC represent the probability of pressure ulcers with nutritional support and standard care, respectively. We followed the algorithm adapted from the algorithm reported in Ades 2004 [33].

Steps 0–3 as in EVPI algorithm above, then:

  1. 4.

    Simulated the variety of possible results of proposed data collection:

    1. 4.1

      Drew a sample from the prior distribution of the RR. The logRR ~Normal (μ 0, τ 0) where μ 0 is logRR in the meta-analysis and τ 0 is its variance.

    2. 4.2

      Drew a sample baseline parameter θ SC from its prior distribution: θ SC~ beta (a, b) where a is the number of patients who developed pressure ulcers and b is the number of patients who did not develop pressure ulcers in the control arm of the meta-analysis.

    3. 4.3

      Transformed back to obtain an implied prior for θ NS : θ NS = θ SCexp(logRR)

  2. 5.
    1. 5.1

      Drew a sample sufficient statistic D, in this case a Binominal numerator, for each arm in the future trialwith size n, assuming equal size arms: r SC ~ Binomial(θ SC, n) and r NS ~ Binomial(θ NS, n)

    2. 5.2

      Converted the sufficient statistics to a mean andvariance using the normal approximation:

      μ D  = log[r NS × n/r SC × n],

      τ D  = [(n − r SC)/(r SC × n) + (n − r NS)/(r NS × n)]−1

  3. 6.

    Updated the prior with the new simulated data to obtain parameters of the posterior distribution:

logRR|D ~ Normal((μ 0 × τ μ D ,τ D )/(τ τ D ), τ τ D )

To allow EVSI calculation using TreeAge software, steps 4–6 were performed using Microsoft Excel and repeated 1,000 times generating a ‘coda’ of updated distributions (outer loop). This coda was then transferred to TreeAge for sampling:

  1. 7.

    Carried out a nested Monte Carlo simulation (inner loop) drawing 1,000 samples from each posterior distribution of the parameters logRR|D in the Excel coda and from the prior distributions of θ c, and identified the intervention that has the highest estimated expected NB.

  2. 8.

    Calculated the average NB of the preferred interventions identified in Step 7.

  3. 9.

    The EVSI is the difference between the average NBs in Steps 8 and 3.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tuffaha, H.W., Roberts, S., Chaboyer, W. et al. Cost-Effectiveness and Value of Information Analysis of Nutritional Support for Preventing Pressure Ulcers in High-risk Patients: Implement Now, Research Later. Appl Health Econ Health Policy 13, 167–179 (2015). https://doi.org/10.1007/s40258-015-0152-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40258-015-0152-y

Keywords

Navigation